surpass 6 tirzepatide Effects of versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial Kidney Outcomes in SURPASS: Exploring

If you stop treatment When you discontinue a GLP-1 medication, whether through stopping tirzepatide or stopping semaglutide , appetite and food intake typically increase

Ultimately, this data aligns with conclusions from regulatory bodies like the FDA, which, after its own review, stated it has "not found evidence that use of these medications causes suicidal thoughts or actions." Takeaway 3: Who Was Studied Matters, A Critical Caveat While the results are broadly reassuring, it is crucial to understand who was included in these trials

Nat Chem Biol (2010) 6:6104

Retatrutide may be the more exciting name in todays weight-loss conversation, but tirzepatide remains the more practical option for patients who are looking for a treatment they can realistically discuss and begin now under proper medical supervision